Skip to main content
Home News

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

See what’s new.

https://otc.duke.edu/wp-content/uploads/2023/03/anna-kudla-story-featured-image.jpeg

From rainforest to RTI International: Anna Kudla, PhD, on applied and basic science

Duke Biology PhD graduate Anna Kudla reflects on her transition from researching treehoppers to technology commercialization and consulting.

Read More

https://otc.duke.edu/wp-content/uploads/2023/03/evecxia-logo.png

Evecxia Therapeutics Reports Favorable Data From a Phase 1 Single Ascending Dose Safety/Tolerability/PK/PD Trial of EVX-301

Evecxia Therapeutics is a Duke University start-up, founded by inventors Drs. Jacob Jacobsen and Marc Caron (Cell Biology, SOM) around their serotonin synthesis amplification therapeutic technology for mental health applications.

Read More

https://otc.duke.edu/wp-content/uploads/2023/03/Isolere-acquisition-story-cover.jpeg

Isolere Bio: Inside the journey of a Duke biotech start-up

From an invention in 1999, to start-up creation in 2017, to acquisition in 2023, learn of the twists and turns of Duke start-up Isolere Bio from its co-founders.

Read More

https://otc.duke.edu/wp-content/uploads/2023/03/Watch-Basics-of-Copyright-Data-and-Software-Intellectual-Property-recording-now-available-Large.jpeg

Watch: Basics of Copyright, Data, and Software Intellectual Property – recording now available

It has been said that content is king. Watch Duke's Daniel Dardani give an overview of copyright law with considerations of its history and relevance to IP.

Read More

https://otc.duke.edu/wp-content/uploads/2023/02/Four-Points-first-project-announcement-Duke-UoM-Ninevah-banner-v2.jpeg

Four Points Innovation Funds Research Collaboration Between Duke University and The University of Manchester

This investment aims to accelerate research to develop a novel therapy to treat a genetic condition called Alport syndrome.

Read More

https://otc.duke.edu/wp-content/uploads/2023/02/isolere-logo.png

Donaldson Acquires Isolere Bio, Continuing to Build Life Sciences Business

“Isolere is thrilled to join the Donaldson family and bring our novel affinity-phase separation technology to market,” said Kelli Luginbuhl, Ph.D, co-founder and chief executive officer of Isolere.

Read More

https://otc.duke.edu/wp-content/uploads/2023/02/Xilis-logo.jpeg

Xilis and MD Anderson Announce Strategic Collaboration to Advance Novel Technology and Accelerate Therapeutic Development

Preclinical research agreement brings together Duke start-up Xilis' MicroOrganoSphere™ platform with MD Anderson's expertise in cancer research and therapeutic development.

Read More

https://otc.duke.edu/wp-content/uploads/2023/02/Screen-Shot-2023-02-08-at-2.44.42-PM.jpeg

Sparta Biomedical, Dr. Wiley highlighted by WXII 12 News

Professor of Chemistry Dr. Benjamin Wiley was interviewed recently by Winston-Salem TV station WXII 12 News about the synthetic cartilage his lab developed.

Read More

https://otc.duke.edu/wp-content/uploads/2023/02/Manny-stockman-summary-featured-Jan-2023.png

Video and Slides: Manny Stockman Seminar on Start-Up Founding

On January 31st, 2023, Manny Stockman of the venture capital investment firm Osage University Partners, delivered a talk titled: Start-Up Seminar: Founders Equity, Dilution Planning, and Term Sheets. In this post you will find the…

Read More

1 2 3 41